Phibro Animal (Germany) Top Insiders

PB8 Stock  EUR 20.00  0.00  0.00%   
Phibro Animal employs about 1.9 K people. The company is managed by 17 executives with a total tenure of roughly 174 years, averaging almost 10.0 years of service per executive, having 109.41 employees per reported executive. Examination of Phibro Animal's management performance can provide insight into the company performance.
Jack Bendheim  Chairman
Chairman of the Board, President, Chief Executive Officer, Director
Thomas Dagger  President
Senior Vice President General Counsel, Corporate Secretary
  
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Phibro Animal Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Phibro Animal Management Team Effectiveness

The company has return on total asset (ROA) of 0.0532 % which means that it generated a profit of $0.0532 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1428 %, meaning that it generated $0.1428 on every $100 dollars invested by stockholders. Phibro Animal's management efficiency ratios could be used to measure how well Phibro Animal manages its routine affairs as well as how well it operates its assets and liabilities.

Phibro Animal Workforce Comparison

Phibro Animal Health is considered to be number one stock in number of employees category among its peers. The total workforce of Drug Manufacturers—Specialty & Generic industry is at this time estimated at about 39,084. Phibro Animal holds roughly 1,860 in number of employees claiming about 5% of equities under Drug Manufacturers—Specialty & Generic industry.
The company has Profit Margin (PM) of 0.04 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.08 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.08.

Phibro Animal Health Benchmark Summation

Operator
The output start index for this execution was zero with a total number of output elements of sixty-one. Phibro Animal Health Price Series Summation is a cross summation of Phibro Animal price series and its benchmark/peer.

Phibro Animal Notable Stakeholders

A Phibro Animal stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Phibro Animal often face trade-offs trying to please all of them. Phibro Animal's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Phibro Animal's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Jack BendheimChairman of the Board, President, Chief Executive Officer, DirectorProfile
Thomas DaggerSenior Vice President General Counsel, Corporate SecretaryProfile
Daniel BendheimExecutive Vice President, Corporate Strategy and DirectorProfile
Lisa EscuderoSenior Vice President of Human ResourcesProfile
Richard JohnsonChief Financial OfficerProfile
Larry MillerChief Operating OfficerProfile
Gerald CarlsonIndependent DirectorProfile
Mary MalanoskiIndependent DirectorProfile
Sam GejdensonIndependent DirectorProfile
Carol WrennIndependent DirectorProfile
Ramon FuenmayorPres RegionProfile
Jonathan BendheimDirector and President MACIE Region and General Manager of Israel OperationsProfile
E CorcoranIndependent DirectorProfile
Damian FinioChief OfficerProfile
Jean FilippiPres RegionProfile
Rob AukermanPresident North America RegionProfile
Anthony AndolinoVice President - Finance, TreasurerProfile

About Phibro Animal Management Performance

The success or failure of an entity such as Phibro Animal Health often depends on how effective the management is. Phibro Animal management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Phibro management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Phibro management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Phibro Animal Health Corporation develops, manufactures, and supplies a range of animal health and mineral nutrition products for livestock primarily in the United States. Phibro Animal Health Corporation was incorporated in 2014 and is headquartered in Teaneck, New Jersey. PHIBRO ANIMAL operates under Drug ManufacturersSpecialty Generic classification in Germany and is traded on Frankfurt Stock Exchange. It employs 1725 people.

Phibro Animal Workforce Analysis

Traditionally, organizations such as Phibro Animal use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Phibro Animal within its industry.

Phibro Animal Manpower Efficiency

Return on Phibro Animal Manpower

Revenue Per Employee506.6K
Revenue Per Executive55.4M
Net Income Per Employee26.4K
Net Income Per Executive2.9M

Complementary Tools for Phibro Stock analysis

When running Phibro Animal's price analysis, check to measure Phibro Animal's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Phibro Animal is operating at the current time. Most of Phibro Animal's value examination focuses on studying past and present price action to predict the probability of Phibro Animal's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Phibro Animal's price. Additionally, you may evaluate how the addition of Phibro Animal to your portfolios can decrease your overall portfolio volatility.
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity